HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 23, 20974-20978, June 7, 2002

This Article Abstract Full Text (PDF) All Versions of this Article: 277/23/20974    most recent M202504200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Milutinovic, S. Articles by Szyf, M. Search for Related Content PubMed PubMed Citation Articles by Milutinovic, S. Articles by Szyf, M. Social Bookmarking                      What's this?

Proliferating Cell Nuclear Antigen Associates with Histone Deacetylase Activity, Integrating DNA Replication and Chromatin Modification^*

Snezana Milutinovic, Qianli Zhuang, and Moshe Szyf^§

From the Department of Pharmacology and Therapeutics, McGill University, 3655 Drummond Street, Montreal, Quebec H3G 1Y6, Canada

Received for publication, March 14, 2002

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Faithful inheritance of the chromatin structure is essential for maintaining the gene expression integrity of a cell. Histone modification by acetylation and deacetylation is a critical control of chromatin structure. In this study, we test the hypothesis that histone deacetylase 1 (HDAC1) is physically associated with a basic component of the DNA replication machinery as a mechanism of coordinating histone deacetylation and DNA synthesis. Proliferating cell nuclear antigen (PCNA) is a sliding clamp that serves as a loading platform for many proteins involved in DNA replication and DNA repair. We show that PCNA interacts with HDAC1 in human cells and in vitro and that a considerable fraction of PCNA and HDAC1 colocalize in the cell nucleus. PCNA associates with histone deacetylase activity that is completely abolished in the presence of the HDAC inhibitor trichostatin A. Trichostatin A treatment arrests cells at the G₂-M phase of the cell cycle, which is consistent with the hypothesis that the proper formation of the chromatin after DNA replication may be important in signaling the progression through the cell cycle. Our results strengthen the role of PCNA as a factor coordinating DNA replication and epigenetic inheritance.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Epigenetic markings play an essential role in regulating the gene expression program of vertebrate cells. One of the fundamental challenges of cell division is therefore coordinating the processes of genetic and epigenetic inheritance. The cell must possess multiple mechanisms to coordinate these processes (1). For example, DNA methylation is coordinated with DNA replication (2) by physical association of maintenance DNA methyltransferase 1 with the DNA replication fork protein PCNA¹ (3). Inhibition of DNA methyltransferase 1 leads to inhibition of initiation of DNA replication (4).

Similar to DNA methylation, DNA replication-coupled chromatin assembly is essential for the inheritance of the epigenetic code. The specific targeting of nucleosome assembly to the newly synthesized DNA is achieved by direct interaction of histone chaperone CAF-1 with PCNA (5). PCNA is a homotrimeric protein that forms a sliding clamp around DNA and functions as a DNA polymerase processivity factor during replication and nucleotide excision repair. Through its multiple protein-protein interactions, PCNA coordinates events in replication, epigenetic inheritance, repair, and cell cycle control (6). A recent study in Saccharomyces cerevisiae has shown that several mutations in PCNA decrease silencing at telomeres and at the mating-type HMR locus (7). Furthermore, mutations in the Drosophila PCNA gene mus209 suppress repression in the vicinity of heterochromatin (8). The disruption of epigenetic silencing has been attributed to the inability of some of these mutants to associate with CAF-1. However, synergism of several PCNA mutants with CAF-1 mutants suggested that PCNA may participate in silencing through another factor.

During nucleosome assembly, histones H3 and H4 undergo transient acetylation before their deposition onto replicated DNA. In the process of chromatin maturation, newly deposited acetylated histones are generally deacetylated by a mechanism that is poorly understood (9).

In this study, we tested whether HDAC1 could be involved in this process. HDAC1 is a member of a growing family of proteins that currently consists of 16 isoforms divided into three classes (10). HDACs have been found in multiprotein complexes involved in transcriptional regulation, cell cycle, differentiation, and DNA repair. HDAC1 and HDAC2 have been shown to associate with the NuRD nucleosome remodeling complex (11) as well as with the mammalian transcription repressor Sin3 and to be targeted to promoter elements to cause transcriptional repression (12). Recruitment of HDAC1 by retinoblastoma protein (Rb) to E2F1-responsive promoters supports its role in cell cycle regulation (13, 14). In addition, HDAC1 and HDAC2 have been shown to associate with DNA methyltransferase 1 and play a role in transcriptional silencing (15, 16), thereby establishing a link between two major epigenetic modifications: DNA methylation and histone deacetylation.

Similar to DNA replication, DNA repair machinery utilizes chromatin remodeling activities to make the DNA more accessible and to reestablish the proper chromatin structure after DNA repair. In accordance, Hus1 and Rad9, two human checkpoint proteins, were shown to form a complex with HDAC1 (17). In addition, another histone-modifying enzyme, histone acetyltransferase p300, has been shown to form a complex with PCNA and was proposed to play a role in DNA repair after UV-induced DNA damage (18).

We therefore tested the hypothesis that similar to DNA methyltransferase 1 and CAF-1, HDAC1 associates with PCNA, which may serve as a recruiting factor for histone deacetylases to the sites of DNA replication and repair. We also tested the hypothesis that disruption of HDAC activity would disrupt cell cycle progression.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Cell Culture and Transfections-- A549 human non-small cell lung carcinoma cells (ATCC CCL 185) were grown in low-glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 2 mM glutamine. HEK293 human adenovirus type 5-transformed human embryonal kidney cells (ATCC CRL 1573) were grown in high-glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 2 mM glutamine. MRHF male human foreskin fibroblasts (72-213A; BioWhittaker) were grown in high-glucose Dulbecco's modified Eagle's medium supplemented with 2% fetal calf serum and 2 mM glutamine. For transient transfections, HEK293 cells were plated 18 h before transfection at a concentration of 5 × 10⁵ cells/100-mm tissue culture dish. 6 µg of pcDNA3-HDAC1-F plasmid (a kind gift from Dr. T. Kouzarides) (15) were transfected using the calcium-phosphate precipitation method. The medium was replaced 24 h after transfection, and the cells were harvested 48 h after transfection.

Purification of GST Fusion Proteins-- GST-HDAC1 fusion constructs were a kind gift from Dr. T. Kouzarides (15). GST and GST fusion proteins were expressed in Escherichia coli XA90, induced with 0.1 mM isopropyl-1-thio--D-galactopyranoside for 4 h, and purified following the protocol from Amersham Biosciences, with modifications. To isolate fusion proteins from inclusion bodies, the bacterial pellet was lysed in STE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, and 150 mM NaCl) on ice, lysozyme was added to a final concentration of 0.1 mg/ml, and incubation was continued for an additional 15 min on ice. Triton X-100 was then added to a final concentration of 2%, and the samples were sonicated and centrifuged at 12,000 rpm. The supernatants were bound to glutathione-Sepharose beads, and the concentrations of the different fusion proteins were estimated by subjecting small portions of the samples to SDS-PAGE. Equal amounts of the fusion proteins were used in the binding assays, whereas glutathione-Sepharose beads were added to the binding mixtures to achieve equal amount of beads in the binding reactions.

GST Pull-down Experiments-- Equal amounts of GST fusion proteins bound to the glutathione-Sepharose beads were incubated in radioimmune precipitation buffer (9.1 mM Na₂HPO₄, 1.7 mM NaH₂PO₄, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS) with 2 mg of total cell extracts prepared from either A549 or HEK293 cells and pre-cleared with beads alone. The binding reaction was incubated by rocking overnight at 4 °C. The beads were washed four times with 1 ml of radioimmune precipitation buffer, subjected to SDS-PAGE, and analyzed by Western blotting. PCNA was transcribed/translated in vitro using the coupled transcription translation system (Promega) from pHPCNA15 vector (a kind gift from Dr. Edward K. L. Chan) (19). We performed pull-down assays with in vitro translated PCNA as described previously (15), adding Complete Mini protease inhibitors (Roche Molecular Biochemicals) in all buffers.

Immunoprecipitations and Western Blot Analysis-- Total cell extract was prepared in radioimmune precipitation buffer containing Complete Mini protease inhibitors (Roche Molecular Biochemicals). For immunoprecipitations, 2 mg of cell extract were incubated with 10 µl of agarose-conjugated PCNA antibody (PC10; Santa Cruz Biotechnology) or agarose-conjugated mouse IgG by rocking overnight at 4 °C. Bound complexes were washed four times with 1 ml of PBS (9.1 mM Na₂HPO₄, 1.7 mM NaH₂PO₄, and 150 mM NaCl) and resolved on SDS-polyacrylamide gels. After transferring to polyvinylidene difluoride membrane and blocking the nonspecific binding with 5% milk, HDAC1, PCNA, and FLAG-tagged proteins were detected using a 1:1000 dilution of HDAC1 antibody (H-51; Santa Cruz Biotechnology), a 1:1000 dilution of PCNA antibody (PC-10; Santa Cruz Biotechnology), and a 1:5000 dilution of FLAG antibody (M2; Sigma), respectively. Peroxidase-conjugated anti-rabbit IgG (A0545; Sigma) and anti-mouse IgG (115035-146; Jackson ImmunoResearch) were used at dilutions of 1:5000 and 1:20,000, respectively, followed by enhanced chemiluminescence detection (Amersham Biosciences).

Histone Deacetylase Assay-- 1 mg of HEK293 total cell extract was incubated with 10 µl of agarose-conjugated PCNA antibody or agarose-conjugated normal mouse IgG overnight at 4 °C. The beads were washed four times with 1 ml of PBS and assayed for deacetylase activity using the HDAC Fluorescent Activity Assay/Drug Discovery Kit (AK-500; BIOMOL Research Laboratories). In short, beads were incubated with 100 µM acetylated substrate in 100 µl of assay buffer containing or lacking 1 µM trichostatin A. Incubation of the reaction at 37 °C for 30 min allowed deacetylation of the substrate, which sensitized it to treatment with the developer and produced a fluorophore detectable on a fluorometric reader (excitation at 360 nm and emission at 450 nm).

Immunofluorescence and Confocal Microscopy-- A549 cells were plated on coverslips and grown to 60-70% confluence. The cells were washed with PBS and fixed with 3% paraformaldehyde solution at room temperature for 20 min, followed by fixation in 100% methanol at 20 °C for 10 min. The cells were washed three times with PBS and stained for PCNA, followed by staining for HDAC1. All of the staining steps contained PBS and 0.1% Triton X-100. For PCNA staining, coverslips were blocked with 10% donkey serum for 20 min, incubated with a 1:100 dilution of anti-PCNA antibody (PC-10; Santa Cruz Biotechnology) in 5% serum for 1 h at room temperature, washed three times, incubated with a 1:500 dilution of rhodamine Red-X anti-mouse IgG (715-295-150; Jackson ImmunoResearch) in 5% serum for 45 min at room temperature, and washed three times. The coverslips were blocked again with 10% goat serum for 20 min, incubated with a 1:50 dilution of anti-HDAC1 antibody (H-51; Santa Cruz Biotechnology) in 1.5% serum for 1 h at room temperature, washed three times, incubated with a 1:200 dilution of fluorescein isothiocyanate-conjugated anti-rabbit IgG (sc-2012; Santa Cruz Biotechnology) in 1.5% serum for 45 min at room temperature, and washed three times. The coverslips were mounted onto slides using Immu-mount (Shandon). The staining was analyzed using LSM 510 Laser Scanning Microscopy, version 2.5 (Zeiss). The fields were taken with a magnification of ×63. The inserts were zoomed three additional times.

Cell Cycle Analysis by FACS-- A549 cells were plated at a density of 5 × 10⁵ cells/100-mm plate. The next day, cells were treated with 1 µM trichostatin A (Sigma) for 6, 12, and 24 h. Control cells and treated cells were harvested, washed twice in PBS, and fixed in ice-cold 70% ethanol for 30 min. The fixed cells were stained for DNA with a 50 µg/ml solution of propidium iodide in PBS for 30 min at room temperature. The cells were analyzed for DNA content by FACS.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

PCNA and HDAC1 Form a Complex in Vivo-- To test the hypothesis that PCNA and HDAC1 are physically associated in human cells, we first tested whether they reside in the same multiprotein complex by coimmunoprecipitation assays. Endogenous HDAC1 protein was coimmunoprecipitated by agarose-conjugated anti-PCNA antibody from two human cancer cell lines (A549 and HEK293) as well as from a non-transformed human fibroblast cell line (MRHF), suggesting that the interaction is not unique to the cancer cells (Fig. 1A). Control immunoprecipitation with an equal amount of agarose-conjugated normal mouse IgG failed to precipitate any HDAC1 (Fig. 1A). To further confirm this interaction, HEK293 cells were transiently transfected with FLAG-tagged HDAC1 (HDAC1-F). Anti-PCNA antibody, but not the control mouse IgG, coimmunoprecipitated HDAC1-F (Fig. 1B).

View larger version (26K): [in this window] [in a new window]   Fig. 1.   PCNA and HDAC1 interact in vivo. Coimmunoprecipitations were performed with agarose-conjugated PCNA antibody or normal mouse IgG as described under "Materials and Methods." A, the complexes precipitated from A549, HEK293, and MRHF cells were analyzed by Western blots for the presence of HDAC1 using the anti-HDAC1 antibody. B, complexes precipitated from HEK293 cells transiently transfected with the HDAC1-FLAG construct were analyzed by Western blot using the anti-FLAG antibody.

PCNA Interacts Directly with HDAC1 in Vitro-- To map the interaction domain of HDAC1, we expressed in bacteria and purified three different fragments of HDAC1 fused to GST (Fig. 2A). We used these fusion proteins to carry out GST pull-down assays from total extracts of A549 and HEK293 cells (Fig. 2, B and C). Western blot analysis using anti-PCNA antibody revealed that two of the GST fusion proteins (region 1 (amino acids 1-120) and region 2 (amino acids 150-242)), which span the catalytic domain of HDAC1, associate with endogenous PCNA. These regions were previously shown to interact with human Hus1 protein (17). Interestingly, it was proposed that Hus1, Rad1, and Rad9, three checkpoint Rad proteins, form a PCNA-like ring structure around the DNA during repair. In addition, region 2 of HDAC1 has been shown to bind DNA methyltransferase 1 and play a role in transcriptional repression (15).

View larger version (43K): [in this window] [in a new window]   Fig. 2.   Mapping of the PCNA interaction domain of HDAC1. A, schematic representation of the HDAC1 and the GST fusion proteins. Gray and black boxes indicate catalytic and LXCXE-like Rb-binding domains, respectively. B and C, bacterially expressed and purified GST-HDAC1 fusion proteins bound to glutathione-Sepharose beads were incubated with total cell extracts from HEK293 cells (B) or A549 cells (C). Pull-down of endogenous PCNA was analyzed by Western blots using anti-PCNA antibody. D, GST-HDAC1 fusion proteins were used to pull down in vitro-translated and 35S-labeled PCNA (IVT PCNA). The complexes were resolved on SDS-polyacrylamide gel and visualized by autoradiography.

To test whether the interaction of PCNA and HDAC1 is direct, we translated PCNA in vitro and carried out GST pull-down assays with purified GST-HDAC1 fusion proteins (Fig. 2D). These experiments confirmed that PCNA interacts directly with region 1 and region 2 of HDAC1 but does not interact with GST alone or with region 3 (amino acids 332-482), which contains a LXCXE-like motif previously shown to interact with Rb (14).

PCNA and HDAC1 Colocalize in A549 Cells in Vivo-- To confirm the association of PCNA and HDAC1 in vivo, we carried out colocalization studies in A549 cells (Fig. 3). We stained endogenous PCNA protein with anti-PCNA antibody, followed by a rhodamine-conjugated anti-mouse secondary antibody (red). The same slides were subsequently stained for endogenous HDAC1 protein with anti-HDAC1 antibody, followed by a fluorescein-conjugated anti-rabbit secondary antibody (green). Both proteins showed strong nuclear staining, and the merging of confocal images appeared mainly yellow, indicating that PCNA and HDAC1 colocalize in vivo.

View larger version (34K): [in this window] [in a new window]   Fig. 3.   Colocalization of PCNA and HDAC1 in A549 cells in vivo. A, A549 cells were grown on coverslips and stained with anti-PCNA antibody, followed by rhodamine-conjugated anti-mouse secondary antibody (red). B, the same cells were stained with anti-HDAC1 antibody, followed by fluorescein isothiocyanate-conjugated anti-rabbit secondary antibody (green). C, confocal merge of PCNA and HDAC1 staining shows colocalization (yellow) of PCNA and HDAC1 in the nuclei of A549 cells. The insets show a single cell from the field at a higher magnification.

PCNA Associates with Histone Deacetylase Activity-- To test whether PCNA associates with an active histone deacetylase, we immunoprecipitated endogenous PCNA from HEK293 cells using anti-PCNA or a control mouse IgG antibody (Fig. 4). The precipitated complexes were tested for their ability to deacetylate an acetylated histone substrate. We showed that PCNA associates with deacetylase activity and that this activity is completely abolished when the deacetylase inhibitor trichostatin A (TSA; 1 µM, final concentration) is included in the deacetylation reaction, suggesting that the histone deacetylase activity associated with PCNA is completely sensitive to TSA.

View larger version (18K): [in this window] [in a new window]   Fig. 4.   PCNA associates with histone deacetylase activity. Histone deacetylase activity was precipitated from HEK293 cells using agarose-conjugated PCNA antibody or control mouse IgG as described under "Materials and Methods." The deacetylase activity associated with the precipitated complexes was assessed by their ability to remove an acetyl group from an acetylated substrate. Once the substrate becomes deacetylated, it reacts with the developer to produce a fluorophore detected on a fluorometric reader. In the presence of 1 µM TSA, the deacetylase activity is inhibited. The error bars represent S.D.s of triplicate experiments.

Trichostatin A Arrests A549 Cells at G₂-M-- Because the histone deacetylase activity associated with PCNA is sensitive to TSA, we used TSA to study the functional consequences of inhibition of this activity for the progression of the cell cycle. We treated A549 cells with 1 µM trichostatin A. We followed the cell cycle profile by FACS analysis of control cells and cells treated with TSA for 6, 12, and 24 h (Fig. 5). The normal cell cycle distribution was altered early, after only 6 h, causing the accumulation of cells in G₂-M phase. These results are consistent with the hypothesis that the maturation of chromatin through deacetylation may be involved in the timing of the events that drive the cells from replication to cell division.

View larger version (10K): [in this window] [in a new window]   Fig. 5.   Trichostatin A arrests A549 cells at the G2-M. A549 cells were treated with 1 µM TSA for 6, 12, and 24 h. Cell cycle profile of control and treated cells was followed by FACS analysis. The percentage of cells in G2-M phase is shown.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Efficient assembly of nucleosomes onto newly synthesized DNA is essential for maintaining proper genome function. Chromatin organization is influenced by variations introduced at the nucleosomal level (20). One such variation is the deacetylation of newly assembled nucleosomes, a modification involved in the formation of heterochromatin. The pattern of this modification has to be faithfully inherited during cell division. Studies in yeast (21, 22) and mammalian cells (23) show that inhibition of deacetylation leads to severe defects in chromosome stability. However, the mechanism of histone deacetylation after DNA replication remains poorly understood.

Here, we present evidence that PCNA associates with histone deacetylase 1. Because PCNA is a resident of the DNA replication fork and plays important roles in recruiting proteins to the fork, this physical linkage between PCNA and HDAC1 can explain the deacetylation of histones immediately after DNA replication. We first show that HDAC1 and PCNA coimmunoprecipitate in two cancer cell lines (A549 and HEK293) as well as in a non-transformed cell line (MRHF) (Fig. 1). This indicates that this interaction is universal and is not confined to the cancer cells that might form aberrant complexes. Second, we utilized GST-HDAC1 fusion proteins expressed and purified from bacteria to pull down PCNA from A549 and HEK cells and show that regions 1 and 2, which span the catalytic domain of the HDAC1, both associate with PCNA (Fig. 2, B and C). These regions have previously been shown to interact with the human Hus1 protein involved in DNA repair (17). It has been proposed that Hus1, Rad1, and Rad9, three checkpoint Rad proteins, form a PCNA-like ring structure around the DNA during repair. Therefore, it is likely that this region of HDAC1 recognizes a ring-like structure around DNA and is thus recruited to sites of DNA replication and repair. Third, region 2 of HDAC1 was shown to bind DNA methyltransferase 1 (15), which in turn was shown to bind PCNA (3), which raised the possibility that the interaction between HDAC1 and PCNA is indirect, through DNA methyltransferase 1. To exclude this possibility, we studied the interactions between purified GST-HDAC1 and in vitro-translated PCNA. The same two regions that interact with PCNA in nuclear extracts also interact with in vitro-translated PCNA (Fig. 2D), indicating that the interaction between PCNA and HDAC1 is direct and is not mediated by DNA methyltransferase 1. Fourth, to further confirm the association of HDAC1 and PCNA in living cells, we carried out colocalization studies. Double staining of A549 cells with antibodies against endogenous PCNA and HDAC1 indicated that both proteins localize to the nucleus. The merging of images obtained by confocal microscopy showed that the two proteins colocalize in vivo (Fig. 3).

Fifth, we demonstrate that PCNA recruits a functional histone deacetylase activity that is inhibited by TSA (Fig. 4). However, because HDAC1 is a member of a large family of histone deacetylases, we do not exclude the possibility that other members of the family also bind to PCNA and contribute to the deacetylase activity in the replication fork. Sixth, to test whether deacetylase activity was necessary for the progression of the replication fork during DNA synthesis, we treated A549 cells with TSA and followed their cell cycle by FACS analysis (Fig. 5). If histone deacetylase activity or the presence of HDAC1 was essential for DNA replication per se or for the progress of the replication fork, then the replication fork should have stalled during the S phase of the cell cycle or at the G₁-S boundary after TSA inhibition of HDAC1. In contrast to these predictions, we observed that the cells started to accumulate at the G₂-M phase 6 h after TSA treatment (Fig. 5).

Whereas we cannot formally exclude the possibility that TSA has other effects that might have caused G₂-M arrest, our data are consistent with the hypothesis that histone deacetylase activity is essential for the formation of proper chromatin structure after the synthesis of DNA. A recent study has shown that after DNA replication, PCNA remains associated with DNA and serves as an imprinting factor for the chromatin assembly (5). This provides a window of opportunity for PCNA to load HDAC1 and allow it to modulate chromatin, leading to its maturation.

Why do cells arrest at G₂-M after TSA treatment? It is possible that the disorganized hyperacetylated chromatin interferes either directly with the exit from G₂ or indirectly by failing to signal proper progression through the cell cycle to a putative G₂-M checkpoint. The G₂-M arrest might be induced by a cellular checkpoint that monitors the state of acetylation of the chromatin and guarantees that only cells bearing proper chromatin divide. Such a mechanism might have evolved to guarantee the integrity of the epigenome. This checkpoint might be triggered by the induction of specific genes that are especially sensitive to hyperacetylation of histones and induce G₂-M cell arrest. Additional experiments are required to address these questions and define the mechanisms through which the cell coordinates the inheritance of the histone acetylation pattern with cell cycle checkpoints.

In summary, our data are consistent with a role for PCNA as a coordinator of DNA synthesis, epigenetic inheritance, and cell cycle control. The interaction of PCNA with HDAC1 as well as with DNA methyltransferase 1 and CAF-1 establishes its role in coupling two important processes, DNA replication and epigenetic inheritance.

	ACKNOWLEDGEMENTS

We thank Dr. Tony Kouzarides for the kind gift of pcDNA3-HDAC1-F vector, GST-HDAC1 fusion constructs, and E. coli XA90 and Francois Fuks for helpful suggestions regarding GST fusion protein purification. We also thank Dr. Edward K. L. Chan for the kind gift of pHPCNA15 vector.

	FOOTNOTES

^* This work was supported in part by the Canadian Institute of Health Research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by Philip Baily McGill Majors Fellowship.

^§ To whom correspondence should be addressed. Tel.: 514-398-7107; Fax: 514-398-6690; E-mail: mszyf@pharma.mcgill.ca.

Published, JBC Papers in Press, April 2, 2002, DOI 10.1074/jbc.M202504200

	ABBREVIATIONS

The abbreviations used are: PCNA, proliferating cell nuclear antigen; HDAC, histone deacetylase; TSA, trichostatin A; GST, glutathione S-transferase; PBS, phosphate-buffered saline; FACS, fluorescence-activated cell-sorting.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				K. W. Kohn, M. I. Aladjem, J. N. Weinstein, and Y. Pommier Chromatin Challenges during DNA Replication: A Systems Representation Mol. Biol. Cell, January 1, 2008; 19(1): 1 - 7. [Abstract] [Full Text] [PDF]

				E. Prosperi The fellowship of the rings: distinct pools of proliferating cell nuclear antigen trimer at work FASEB J, May 1, 2006; 20(7): 833 - 837. [Abstract] [Full Text] [PDF]

				E. J. Noh, E. R. Jang, G. Jeong, Y. M. Lee, C. K. Min, and J.-S. Lee Methyl CpG-Binding Domain Protein 3 Mediates Cancer-Selective Cytotoxicity by Histone Deacetylase Inhibitors via Differential Transcriptional Reprogramming in Lung Cancer Cells Cancer Res., December 15, 2005; 65(24): 11400 - 11410. [Abstract] [Full Text] [PDF]

				P. J. Martin, V. Lardeux, and P. Lefebvre The proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct protein-protein interaction Nucleic Acids Res., July 29, 2005; 33(13): 4311 - 4321. [Abstract] [Full Text] [PDF]

				S.-H. Hsu, H.-M. Hsieh-Li, H.-Y. Huang, P.-H. Huang, and H. Li bHLH-zip Transcription Factor Spz1 Mediates Mitogen-Activated Protein Kinase Cell Proliferation, Transformation, and Tumorigenesis Cancer Res., May 15, 2005; 65(10): 4041 - 4050. [Abstract] [Full Text] [PDF]

				S. N. Naryzhny and H. Lee The Post-translational Modifications of Proliferating Cell Nuclear Antigen: ACETYLATION, NOT PHOSPHORYLATION, PLAYS AN IMPORTANT ROLE IN THE REGULATION OF ITS FUNCTION J. Biol. Chem., May 7, 2004; 279(19): 20194 - 20199. [Abstract] [Full Text] [PDF]

				S. Ahmed, C. Palermo, S. Wan, and N. C. Walworth A Novel Protein with Similarities to Rb Binding Protein 2 Compensates for Loss of Chk1 Function and Affects Histone Modification in Fission Yeast Mol. Cell. Biol., May 1, 2004; 24(9): 3660 - 3669. [Abstract] [Full Text] [PDF]

				R. Hong and D. Chakravarti The Human Proliferating Cell Nuclear Antigen Regulates Transcriptional Coactivator p300 Activity and Promotes Transcriptional Repression J. Biol. Chem., November 7, 2003; 278(45): 44505 - 44513. [Abstract] [Full Text] [PDF]

				K. Ghoshal, J. Datta, S. Majumder, S. Bai, X. Dong, M. Parthun, and S. T. Jacob Inhibitors of Histone Deacetylase and DNA Methyltransferase Synergistically Activate the Methylated Metallothionein I Promoter by Activating the Transcription Factor MTF-1 and Forming an Open Chromatin Structure Mol. Cell. Biol., December 1, 2002; 22(23): 8302 - 8319. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 277/23/20974    most recent M202504200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Milutinovic, S. Articles by Szyf, M. Search for Related Content PubMed PubMed Citation Articles by Milutinovic, S. Articles by Szyf, M. Social Bookmarking                      What's this?